Efficacy of anti-interleukin-2 receptor antibody (daclizumab) in reducing the incidence of acute rejection after renal transplantation

Category Primary study
JournalNephro-Urology Monthly
Year 2012
This article has no abstract
Epistemonikos ID: 6e2c46356de74e951863646428e4e529e2bce059
First added on: Feb 04, 2025